
Jennifer Humes
Chief Accounting Officer · Roivant Sciences Ltd.
- 2026
- Sep 23, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer Humes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jennifer Humes?
Jennifer Humes is a corporate insider, tracked as Chief Accounting Officer of Roivant Sciences Ltd. (ROIV). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jennifer Humes submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jennifer Humes been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($384K) across all tracked filings.